blue cross blue shield glp 1 coverage BCBSM pulling back on GLP-1 Insurance Coverage Changes for GLP-1

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

[5] Additionally, some patients may experience changes in lipid profiles, liver enzymes, or kidney function markers as their metabolic health improves or if side effects such as dehydration from gastrointestinal symptoms develop

You might interpret treatment failure as a personal response issue rather than recognizing the medication itself has degraded

While it is possible that the GH-releasing effect of ipamorelin could result in collagen development, tissue repair, skin health, and improved bone density, this is still an area that needs more research before ipamorelin can be declared an elixir of youth [27]